A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
University of Washington
University Medical Center Groningen
University Medical Center Groningen
Dana-Farber Cancer Institute
Eastern Cooperative Oncology Group
Institut Paoli-Calmettes
Vanquish Oncology, Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Iowa
Federation Francophone de Cancerologie Digestive
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)